Stevin Zorn, PhD, discusses research into exploitation of a single mechanism of action for possible treatment and prevention of Alzheimer disease, and a possible shift of focus towards experimenting with...
In this video, Dr Bruce Sands discusses the current role of JAK inhibitors for the treatment of IBD and whether or not gastroenterologists should be concerned with adverse events.
In this video, Cardiology Consultant Advisory Board Member Seth Baum, MD, overviews the intersection between nonalcoholic steatohepatitis and cardiovascular disease, which he calls the "next big threat to...
COPD affects more than 16 million Americans. During his session at the American Lung Association’s LUNGFORCE Expo, Andrew Berman, MD, discussed pharmacologic and nonpharmacologic therapy options for...
